SCHEMBL102409

SCHEMBL102409

CCC(C)CC[NH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11095717 0.85
SCHEMBL3977371 0.81
SCHEMBL5932768 0.79
SCHEMBL19004724 0.78 TSHR (0.40)
SCHEMBL109285 0.78 TSHR (0.40)
SCHEMBL3836543 0.78
SCHEMBL8395179 0.77
SCHEMBL10002586 0.76
SCHEMBL28385524 0.73
SCHEMBL3833969 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104974109-B Propine amide derivatives and its preparation method and pharmaceutical composition and purposes containing thiazole 中国医学科学院药物研究所 2019-10-01 CN claimed
CN-104974109-A Propynamide derivatives containing thiazole as well as preparation method, drug composition and application thereof INST MATERIA MEDICA CAMS 2015-10-14 CN claimed
CN-104974104-A Propynamide derivatives containing oxazole as well as preparation method, drug composition and application thereof INST MATERIA MEDICA CAMS 2015-10-14 CN claimed
WO-2009129371-A1 CATHEPSIN C INHIBITORS GLAXO GROUP LIMITED (GB) 2009-10-22 WO claimed
US-20090264499-A1 Cathepsin C Inhibitors GLAXO GROUP LIMITED (GB) 2009-10-22 US claimed
EP-1575947-A1 2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES Amgen Inc. (US) 2005-09-21 EP claimed
WO-2004060890-A1 2-OXOPYRIDIN-3-YL THIA (DI) AZOLE DERIVATES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES AMGEN INC. (US) 2004-07-22 WO claimed
EP-0582790-B1 Novel method of producing 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines AMERICAN CYANAMID CO (US) 1998-12-23 EP claimed
EP-3594282-B1 RUBBER COMPOSITION AND TIRE OTSUKA CHEMICAL CO LTD (JP) 2024-07-17 EP disclosed
CN-112912139-B Biaryl derivatives 第一三共株式会社 2024-07-09 CN disclosed
WO-2024140700-A1 BENZOTHIAZOLE COMPOUND, AND SYNTHESIS THEREFOR AND USE THEREOF 西北农林科技大学 2024-07-04 WO disclosed
WO-2024135828-A1 AVERMECTIN DERIVATIVE Meiji Seikaファルマ株式会社 2024-06-27 WO disclosed
US-12018267-B2 Plants having increased tolerance to herbicides BASF SE (DE) 2024-06-25 US disclosed
CN-118206569-A Azoline ammonium quinoline carboxamide analogue, pharmaceutical composition, preparation method and medical application thereof 上海市针灸经络研究所 2024-06-18 CN disclosed
US-5068222-A Polypeptides for treatment of cancer IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-11-26 US disclosed
EP-0453883-A2 2-amino-4-trichloropyridine derivatives BASF Aktiengesellschaft (DE) 1991-10-30 EP disclosed
EP-0421441-A2 Pantothenic acid derivatives FUJIREBIO INC. (JP) 1991-04-10 EP disclosed
EP-0345990-A2 Polypeptide compounds ZENECA LIMITED (GB) 1989-12-13 EP disclosed
EP-0315367-A2 Polypeptides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-05-10 EP disclosed
US-4545804-A HERBICIDES MONSANTO COMPANY (US) 1985-10-08 US disclosed